Monica Sines never imagined a career in pharmacy. As a driver in Tikrit and Mosul in Iraq, transporting Iranian, Iraqi and Pakistani workers safely to their destinations, 19-year-old Sines witnessed harrowing scenes while serving in the military.
“I saw things that people at that age should not see,” said Sines, who is now 35 and a third year at the College of Pharmacy and Pharmaceutical Sciences pursuing her Doctor of Pharmacy.
Sines joined the military in November 2002 at age 18, just before the March 2003 invasion of Iraq. After six years of service, Sines left the military in 2008 and received her bachelor’s degree … » More …
Prescribe at your own risk. That is the general feeling that most doctors get when prescribing medicine to children. Due to ethical and legal challenges, conducting clinical trials on children has proven to be a major obstacle for drug researchers. In fact, many prescription drugs rarely go through clinical trials using children. As a result, doctors only have two options in pediatric care: 1. Don’t prescribe children drugs shown to be effective in adults, or 2. Prescribe drugs off-label to children at their own risk. That’s where Dr. Bhagwat Prasad, Associate Professor in Pharmaceutical Sciences at WSU, is transforming pediatric precision medicine so that drugs … » More …
Pharmacotherapy Clinical Associate Professor Kimberly McKeirnan and two co-authors published, “The value and potential integration of pharmacy technician national certification into processes that help assure a competent workforce,” in the peer-reviewed journal Pharmacy in September 2019 as part of the Special Issue Pharmacy Workforce Support Personnel. Read article »
Kim McKeirnan and one co-author published, “Implementing immunizing pharmacy technicians in a federal healthcare facility,” in Pharmacy in October 2019 as part of the Special Issue Pharmacy-based Immunization Services. Read article »
Pharmacotherapy Clinical Assistant Professor Lauren Marcath and two co-authors published, “Challenges to assess substrate-dependent allelic effects in CYP450 enzymes … » More …
By Judith Van Dongen, Office of Research, WSU Health Sciences Spokane
SPOKANE, Wash. – A study led by researchers at Washington State University has uncovered a potential new treatment approach for diseases associated with inflammation, including sepsis, stroke, rheumatoid arthritis, acute lung injury, and atherosclerosis.
Published in the open-access journal Science Advances, their paper describes a novel, patent-pending technology that uses nanosized particles to transport cell-killing drugs directly to activated neutrophils, the cells that drive the exaggerated immune response involved in inflammatory diseases. They also demonstrated the technology’s feasibility at selectively killing activated neutrophils without harming other cell types or compromising the immune system.